Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Affiris

    Client Virtual Booth

    AFFIRIS

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Affiris
    Austria Flag
    Country
    Country
    Austria
    Address
    Address
    Karl-Farkas-Gasse 22 1030 Vienna
    Telephone
    Telephone
    +43 (1) 798 15 75 – 300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://affiris.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China
    AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE®AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China

    https://www.pharmacompass.com/pdf/news/affiris-and-frontier-biotechnologies-announce-license-agreement-for-affitopeat04-an-active-immunotherapy-targeting-pcsk9-to-treat-hypercholesterolemia-in-greater-china-1642055496.pdf

    PRESS RELEASE
    22 Dec 2021
    Share Share
    AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9
    AFFiRiS: Positive phase 1 results with immunotherapies targeting PCSK9

    https://www.pharmacompass.com/pdf/news/affiris-positive-phase-1-results-with-immunotherapies-targeting-pcsk9-1624535329.pdf

    GLOBENEWSWIRE
    27 May 2021
    Share Share
    Positive preclinical in vivo results with AFFiRiS’ antibody mAB C6-17
    Positive preclinical in vivo results with AFFiRiS’ antibody mAB C6-17

    https://www.pharmacompass.com/pdf/news/positive-preclinical-in-vivo-results-with-affiris-antibody-mab-c6-17-1622609789.pdf

    PRESS RELEASE
    27 Apr 2021
    Share Share
    AFFiRiS presents positive preclinical in vivo data with antibody mAB C6-17
    AFFiRiS presents positive preclinical in vivo data with antibody mAB C6-17

    http://www.pharmabiz.com/NewsDetails.aspx?aid=138103&sid=2

    PHARMABIZ
    27 Apr 2021
    Share Share
    AFFiRiS Announces FDA to its pre-IND Sub for Phase 2 trial with AFFITOPE PD01
    AFFiRiS Announces FDA to its pre-IND Sub for Phase 2 trial with AFFITOPE PD01

    https://finance.yahoo.com/news/affiris-announces-fda-response-pre-093000849.html

    FINANCE YAHOO
    27 Jan 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search